genomespotter.com | genome sequencing

	genomespotter.com \| genome sequencing
	Home Site Map

IBM Partners with University of Missouri on Genomics Research Initiative
COLUMBIA, Mo., July 2 /PRNewswire-FirstCall/ -- IBM (NYSE: IBM) and the University of Missouri today announced a life sciences research initiative using IBM high performance computing technologies to advance the school's bioinformatics research projects.

Roche and IBM Collaborate to Develop Nanopore-Based DNA Sequencing Technology
YORKTOWN HEIGHTS, N.Y. and BRANFORD, Conn., July 1 /PRNewswire-FirstCall/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) and IBM (NYSE: IBM) announced today an agreement to develop a nanopore-based technology that will directly read and sequence human DNA quickly and efficiently.

SeqWright Expands Genomics Services Offering Through New Partnership With RainDance Technologies
HOUSTON, June 30 /PRNewswire/ -- SeqWright Inc., a world-wide leader in custom genomic and molecular biology services, announced today the expansion of its service portfolio by partnering with RainDance Technologies to offer the company's innovative RainStormâ„¢ microdroplet-based PCR technology.

Caliper Owners Group Meeting Showcases Critical Role of Biopharma and Academic Researchers for Improving Healthcare and Quality of Life
HOPKINTON, Mass., June 25 /PRNewswire-FirstCall/ -- Caliper Life Sciences, Inc. (Nasdaq: CALP), a leading provider of tools and services for drug discovery and life sciences research, hosted its 2010 annual Customers Owners Group (COG 2010) meeting on June 9 and 10.

Local Medical Student Receives National Head Start Scholarship
Bolajoko Adeniyi has always wanted to assist people who were in need of, but couldn’t afford, quality health care. But first the 28-year-old Belleville woman had to take on the high cost of studying medicine.

Existence Genetics is Pioneering the Field of Predictive Medicine - Nexus Technologies Critical in Understanding and Preventing Deadly Disease
Through Existence’s cutting-edge technological advancements, prediction and prevention of a wide range of both common and rare diseases are possible before they ever manifest. The future of medicine starts today.



Yonder Biology Launches "Me", a Personalized DNA Art Portrait Personal DNA Art Is Now More Customized. Synamatix Partners With GeneWorks to Deliver Next-generation Sequencing and Bioinformatics Support for Key Research Institutions in Asia and Australia Synamatix today announced its partnership with GeneWorks for the provision of sequencing and bioinformatics research support to key customers within Asia and Australia. The two companies will provide genome institutes in Asia with an extensive and comprehensive range of sequencing and bioinformatics solutions to support and enhance research. Applied Biosystems Surpasses Industry Milestone in Lowering the Cost of Sequencing Human Genome: Data Made Available to Worldwide Scientific Commun Applied Biosystems (NYSE:ABI), an Applera Corporation business, today announced a significant development in the quest to lower the cost of DNA sequencing. Scientists from the company have sequenced a human genome using its next-generation genetic analysis platform. The sequence data generated by this project reveal numerous previously unknown and potentially medically significant genetic variations. It also provides a high-resolution, whole-genome view of the structural variants in a human genome, making it one of the most in-depth analyses of any human genome sequence. Applied Biosystems is making this information available to the worldwide scientific community through a public database hosted by the National Center for Biotechnology Info ... Universiti Malaysia Sabah Biotechnology Research Institute Partners with Synamatix to Implement Best-of-breed Bioinformatics Solutions Synamatix announced today a research collaboration and the licensing of cutting-edge bioinformatics technologies to Universiti Malaysia Sabah's Biotechnology Research Institute (BRI). The collaboration will also include a research partnership programme, which will enable opportunities for 'national interest' projects with Synamatix customers in the USA, Europe and Asia.

Home Site Map